Naviter Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Buy
3,328
+193
+6% +$105K 0.2% 115
2025
Q4
$1.82M Sell
3,135
-403
-11% -$228K 0.24% 102
2025
Q3
$1.72M Sell
3,538
-316
-8% -$147K 0.2% 126
2025
Q2
$1.56M Sell
3,854
-421
-10% -$176K 0.19% 133
2025
Q1
$2.14M Sell
4,275
-127
-3% -$68.8K 0.26% 107
2024
Q4
$2.29M Buy
4,402
+1,011
+30% +$556K 0.28% 95
2024
Q3
$2.1M Sell
3,391
-169
-5% -$100K 0.29% 98
2024
Q2
$1.97M Buy
3,560
+127
+4% +$72.8K 0.29% 95
2024
Q1
$2M Buy
3,433
+1,210
+54% +$679K 0.33% 82
2023
Q4
$1.18M Sell
2,223
-193
-8% -$93.4K 0.24% 114
2023
Q3
$1.22M Buy
2,416
+218
+10% +$116K 0.3% 83
2023
Q2
$1.15M Buy
2,198
+200
+10% +$108K 0.29% 90
2023
Q1
$1.15M Buy
1,998
+83
+4% +$46.8K 0.4% 68
2022
Q4
$1.11M Buy
1,915
+274
+17% +$145K 0.31% 81
2022
Q3
$833K Buy
1,641
+144
+10% +$80.6K 0.34% 68
2022
Q2
$813K Buy
+1,497
New +$824K 0.33% 72

Other funds holding TMO

Naviter Wealth's TMO Position: Q1 2026 in Review

Naviter Wealth increased its Thermo Fisher Scientific (TMO) stake by 6.2% in Q1 2026, buying an estimated $105K and bringing the position to 3,328 shares worth $1.64M. The position accounts for 0.2% of the portfolio, ranked #115.

Naviter Wealth first reported a position in TMO in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.29M in Q4 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Naviter Wealth held 3,328 shares of Thermo Fisher Scientific worth $1.64M as of Q1 2026.
  • Naviter Wealth bought 193 Thermo Fisher Scientific shares in Q1 2026, an estimated $105K.
  • Thermo Fisher Scientific made up 0.2% of Naviter Wealth's portfolio in Q1 2026, its #115 holding.
  • Naviter Wealth first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 16 quarters since.
  • Naviter Wealth's Thermo Fisher Scientific position peaked at $2.29M in Q4 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.